Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2020 · 10-Q
Revenue$7.47M$7.47M+112.4% vs Q1 2019 Net Income-$2.42M-$2.42MN/M vs Q1 2019 EPS Diluted-$0.01-$0.01— vs Q1 2019 Gross Profit$4,868,102+115.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow-$407,105N/M Free Cash Flowderived-$1,770,274N/M Margins · derivedGross margin65.2%+0.9 pt vs Q1 2019
Operating margin13.5%+19.8 pt vs Q1 2019
Net margin-32.4%−31.8 pt vs Q1 2019
ended Mar 31, 2020 · filed May 28, 2020 · 58 d after period end